Are particular Epstein-Barr virus strains linked to disease?

Seminars in Cancer Biology

Volumn 7, Issue 4, 1996, Pages 209-215

  Jenkins, Peter J ^a   Farrell, Paul J ^a,b  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Burkitt's lymphoma; EBNA; Epstein Barr virus; LMP1; Nasopharyngeal carcinoma

Indexed keywords

MEMBRANE PROTEIN;

ARTICLE; BURKITT LYMPHOMA; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; NASOPHARYNX CARCINOMA; NONHUMAN; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS GENE; VIRUS TYPING;

EID: 0030221849     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1996.0028     Document Type: Article

References (52)

1. 1. Kieff E (1996) Epstein-Barr virus and its replication, in Fields Virology (Fields BN, Knipe DM, Howley PM, eds) pp 2343-2396. Lippincott-Raven, Philadelphia
2. 2. Rickinson AB, Kieff E (1996) Epstein-Barr virus, in Fields Virology (Fields BN, Knipe PM, Howley PM, eds) pp 2397-2446. Lippincott-Raven, Philadelphia
3. 3. Baer R, Bankier AT, Biggin MD, Deininger PL, Farrell PJ, Gibson TJ, Hatfull G, Hudson GS, Satchwell SC, Seguin C, Tuffnell PS, Barrell BG (1984) DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211
4. 4. Arrand JR, Young LS, Tugwood JD (1989) Two families of sequences in the small RNA-encoding region of Epstein-Barr virus (EBV) correlate with EBV types A and B. J Virol 63:983-986
5. 5. Schuster V, Ott G, Seidenspinner S, Kreth HW (1996) Common Epstein-Barr virus (EBV) type-1 variant strains in both malignant and benign EBV associated disorders. Blood 87:1579-1585
6. 6. Rickinson AB, Young LS, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 in the growth phenotype of virus transformed B cells. J Virol 61:1310-1317
7. 7. Zimber U, Adldinger HK, Lenoir GM, Vuillaume M, Knebel-Doeberitz MV, Laux G, Desgranges C, Wittmann P, Freese UK, Schneider U et al (1986) Geographical prevalence of two types of Epstein-Barr virus. Virology 154:56-66
8. 8. Young LS, Yao QY, Rooney CM, Sculley TB, Moss DJ, Rupani H, Laux G, Bornkamm GW, Rickinson AB (1987) New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J Gen Virol 68:2853-2862
9. 9. Sixbey JW, Shirley P, Chesney PJ, Buntin DM, Resnick L (1989) Detection of a second widespread strain of Epstein-Barr virus. Lancet 2:761-765
10. 10. Kyaw MT, Hurren L, Evans L, Moss DJ, Cooper DA, Benson E, Esmore D, Sculley TB (1992) Expression of B-type Epstein-Barr virus in HIV-infected patients and cardiac transplant recipients. Aids Res Hum Retroviruses 8:1869-1874
11. 11. Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA (1990) Coinfection with A-and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis 162:643-648
12. 12. Walling DM, Edmiston SN, Sixbey JW, Abdel-Hamid M, Resnick L, Raab-Traub N (1992) Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci USA 89:6560-6564
13. 13. Boyle MJ, Vasak E. Tschuchnigg M, Turner JJ, Sculley T, Penny R, Cooper DA, Tindall B, Sewell WA (1993) Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood 81:468-474
14. 14. Boyle MJ, Sewell WA, Sculley TB, Apolloni A, Turner JJ, Swanson CE, Penny R, Cooper DA (1991) Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 78:3004-3011
15. 15. Birx DL, Redfield RR, Tosato G (1986) Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 314:874-879
16. 16. Gratama JW, Erberg I (1995) Molecular epidemiology of Epstein-Barr virus infection. Adv Cancer Res 67:197-255
17. 17. Abdel-Hamid M, Chen JJ, Constantine N, Massoud M, Raab-Traub N (1992) EBV strain variation: geographical distribution and relation to disease state. Virology 190:168-175
18. 18. Murray RJ, Kurilla MG, Brooks JM, Thomas WA, Rowe M, Kieff E, Rickinson AB (1992) Identification of target antigens for the human cytotoxic T cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positive malignancies. J Exp Med 176:157-168
19. 19. Gavioli R, Kurilla MG, de-Campos-Lima PO, Wallace LE, Dolcetti R, Murray RJ, Rickinson AB, Masucci MG (1993) Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol 67:1572-1578
20. 20. de-Campos-Lima PO, Levitsky V, Brooks J, Lee SP, Hu LF, Rickinson AB, Masucci MG (1994) T cell responses and virus evolution: loss of HLA A11-restricted CTL epitopes in Epstein-Barr virus isolates from highly All-positive populations by selective mutation of anchor residues. J Exp Med 179:1297-1305
21. 21. Wang D, Liebowitz D, Kieff E (1985) EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 43:831-840
22. 22. Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N (1995) Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med 333:693-698
23. 23. Huen DS, Henderson SA, Croom-Carter D, Rowe M (1995) The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene 10:549-560
24. 24. Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G (1991) Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 72:2399-2409
25. 25. Hu LF, Chen F, Zheng X, Ernberg I, Cao SL, Christensson B, Klein G, Winberg G (1993) Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1. Oncogene 8:1575-1583
26. 26. Chen ML, Tsai CN, Liang CL, Shu CH, Huang CR, Sulitzeanu D, Liu ST, Chang YS (1992) Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140
27. 27. Li S-N, Chang Y-S, Liu S-T (1996) Effect of a 10 amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein-Barr virus. Oncogene 12:2129-2135
28. 28. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Young LS (1991) Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320-322
29. 29. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G (1993) Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937-2942
30. 30. Sandvej K, Peh SC, Andresen BS, Pallesen G (1994) Identification of potential hot spots in the carboxyl-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp depletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053-4060
31. 31. Vasef MA, Kamel OW, Chen Y-Y, Medeiros LJ, Weiss LM (1995) Detection of Epstein-Barr virus in multiple sites involved by Hodgkin's disease. Am J Path 147:1408-1415
32. 32. Knecht H, Martius F, Bachmann E, Hoffman T, Zimmermann DR, Rothenberger S, Sandvej K, Wegmann W, Hurwitz N, Odermatt BF et al (1995) A deletion mutant of the LMP1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 9:458-465
33. 33. Cheung S-T, Lo K-W, Leung SF, Chan W-Y, Choi PHK, Johnson PJ, Lee JCK, Huang DP (1996) Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer 66:711-712
34. 34. Lung ML, Chang RS, Huang ML, Guo HY, Choy D, Sham J, Tsao SY, Cheng P, NG MH (1990) Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology 177:44-53
35. 35. Lung ML, Lam WP, Sham J, Choy D, Yong-Sheng Z, Guo HY, Ng MH (1991) Detection and prevalence of the 'f' variant of Epstein-Barr virus in southern China. Virology 185:67-71
36. 36. Lung ML, Chang GC, Miller TR, Wara WM, Phillips TL (1994) Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States. Int J Cancer 59:743-746
37. 37. Lung ML, Chang GC (1992) Detection of distinct Epstein-Barr virus genotypes in NPC biopsies from southern Chinese and Caucasians. Int J Cancer 52:34-37
38. 38. Joab I, Nicolas JC, Schwaab G, de-The G, Clausse B, Perricaudet M, Zeng Y (1991) Detection of anti-Epstein-Barr-virus trans-activator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int J Cancer 48:647-649
39. 39. Yip TT, Ngan RK, Lau WH, Poon YF, Joab I, Cochet C, Cheng AK (1994) A possible prognostic role of immunoglobulin-G antibody against recombinant Epstein-Barr virus BZLF-1 trans-activator protein ZEBRA in patients with nasopharyngeal carcinoma. Cancer 74:2414-2424
40. 40. Farrell PJ, Rowe DT, Rooney CM, Kouzarides T (1989) Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP-1 site and is related to c-fos. EMBO J 8:127-132
41. 41. Zhang Q, Gutsch D, Kenney S (1994) Functional and physical interaction between p53 and BZLF1: Implications for Epstein-Barr virus latency. Molec Cell Biol 14:1929-1938
42. 42. Packham G, Brimmell M, Cook D, Sinclair AJ, Farrell PJ (1993) Strain variation in Epstein-Barr virus immediate early gene. Virology 192:541-550
43. 43. Sixbey JW, Shirley P, Sloas M, Raab-Traub N, Israele V (1991) A transformation-incompetent, nuclear antigen 2-deleted Epstein-Barr virus associated with replicative infection. J Infect Dis 163:1008-1015
44. 44. Can YJ, Shirley P, Zeng Y, Sixbey JW (1993) Human oropharyngeal lesions with a defective Epstein-Barr virus that disrupts viral latency. J Infect Dis 168:1349-1355
45. 45. Patton DF, Ribeiro RC, Jenkins JJ, Sixbey JW (1994) Thymic carcinoma with a defective Epstein-Barr virus encoding the BZLF1 trans-activator. J Infect Dis 170:7-12
46. 46. Walling DM, Clark NM, Markovitz DM, Frank TS, Braun DK, Eisenberg E, Krutchkoff DJ, Felix DH, Raab-Traub N (1995) Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis 171:1122-1130
47. 47. Gratama JW, Oosterveer MA, Klein G, Ernberg I (1990) EBNA size polymorphism can be used to trace Epstein-Barr virus spread within families. J Virol 64:4703-4708
48. 48. Falk K, Gratama JW, Rowe M, Zou JZ, Khanim F, Young LS, Oosterveer RAP, Ernberg I (1995) The role of repetitive DNA sequences in the size variation of Epstein-Barr (EBV) nuclear antigens and the identification of different EBV isolates using RFLP and PCR analysis. J Gen Virol 76:779-790
49. 49. Snudden DK, Smith PR, Lai D, Ng M-H, Griffin BE (1995) Alterations in the structure of the EBV nuclear antigen, EBNA1, in epithelial cell tumours. Oncogene 10:1545-1552
50. 50. Wrightham MN, Stewart JP, Janjua NJ, Pepper SD, Sample C, Rooney CM, Arrand JR (1995) Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. Virology 208:521-530
51. 51. Bhatia K, Raj A, Gutierrez MI, Judde J-G, Spangler G, Venkatesh H, Magrath IT (1996). Variation in the sequence of Epstein-Barr virus nuclear antigen 1 in normal peripheral blood lymphocytes and in Burkitt's lymphomas. Oncogene 13:177-181
52. 52. Burrows JM, Khanna R, Sculley TB, Alpers MP, Moss DJ, Burrows SR (1996) Identification of a naturally occuring recombinant Epstein-Barr virus isolate from New Guinea that encodes both Type 1 and Type 2 nuclear antigen sequences. J Virol 70:4829-4833